Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Sun Joo Cha, Kiyoung Kim
Format: Artykuł
Język:English
Wydane: MDPI AG 2022-01-01
Seria:Antioxidants
Hasła przedmiotowe:
edaravone
oxidative stress
antioxidant
mitochondria
neurodegenerative disease
amyotrophic lateral sclerosis
Dostęp online:https://www.mdpi.com/2076-3921/11/2/195

Internet

https://www.mdpi.com/2076-3921/11/2/195

Podobne zapisy